Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,439 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,009
Ph III recruiting: 99
Growth YoY: −2.8%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,350)

clinicaltrialsPublishedShowing 551–600 of 8,439 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03680677	Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies	recruiting	—	20	Abramson Cancer Center at Penn MedicineOTHER	1	Aug 12, 2026	clinicaltrials
NCT04307576	A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia	recruiting	Phase 3	6,430	Mats HeymanOTHER	15	Aug 12, 2026	clinicaltrials